semaglutide: 0.51.0 mg/week in Japan)
2017 Cell study used 5 mg/kg intraperitoneal injection three times per week in aged mice, with treatment periods of several weeks the three-times-weekly dosing suggests the peptide maintains sufficient functional concentrations for at least 48-72 hours per dose (PMID: 28340339)
Semaglutide, found in the weight-loss drug Wegovy, and the drug tirzepatide, which is in the weight-loss medication Zepbound and the diabetes drug Mounjaro, are whats known as glucagon-like peptide-1 (GLP-1) receptor agonists
However, further research is needed to evaluate its impact on HF outcomes in clinical settings [21]
Food Chemistry, Volume 86, Issue 1, June 2004, Pages 137142 W.H
Numerous studies have suggested that GLP-1 RAs may lead to mood-related adverse reactions